Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Original Articles: Central Nervous System

Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients

Elsaka, Rasha MD, PhD*; Kitagwa, Joan Minyika MD; Refaat, Tamer MD, PhD, MSCI*,‡; Mahmoud, Amr A. MD§; Shaikh, Hamza; Meheissen, Mohamed A.M. MD, PhD*; Elsaid, Amr Abdelaziz MD*

Author Information
American Journal of Clinical Oncology 46(3):p 101-106, March 2023. | DOI: 10.1097/COC.0000000000000983

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid